Showing results (51-60 of 335) with videos related to
Sort By:
Pageof 34
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Irinotecan pathway genotype analysis to predict pharmacokineticsRon H J Mathijssen, Sharon Marsh, Mats O Karlsson, et al.Journal of the American Heart Association|December 30, 2022
Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor-Induced Blood Pressure Rise: A Clinical Cohort StudyDaan C H van Dorst, Sumeyye Kabadayi, Esther Oomen-de Hoop, et al.Cancers|March 6, 2021
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a ControversyTessa A M Mulder, Mirjam de With, Marzia Del Re, et al.Journal of Pharmaceutical and Biomedical Analysis|June 30, 2015
Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hairJan C Drooger, Agnes Jager, Mei-Ho Lam, et al.European Journal of Cancer (Oxford, England : 1990)|October 1, 2021
Therapeutic drug monitoring in oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology consensus guidelines for imatinib therapyWilliam A Clarke, Etienne Chatelut, Alan K Fotoohi, et al.Journal of Clinical Pharmacology|August 3, 2004
Influence of genetic variants in UGT1A1 and UGT1A9 on the in vivo glucuronidation of SN-38Luca Paoluzzi, Arun S Singh, Douglas K Price, et al.Cancer Treatment Reviews|May 19, 2015
Inter-patient variability in docetaxel pharmacokinetics: A reviewAnnemieke J M Nieuweboer, Ellen S de Morrée, Anne-Joy M de Graan, et al.Thyroid : Official Journal of the American Thyroid Association|February 1, 2011
Sorafenib induced thyroiditis in two patients with hepatocellular carcinomaLeni van Doorn, Ferry A L M Eskens, Theo J Visser, et al.Journal of Pharmaceutical and Biomedical Analysis|January 11, 2024
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasmaBarend J Sikkema, Ron H J Mathijssen, Debbie G J Robbrecht, et al.Clinical Pharmacokinetics|August 2, 2017
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover TrialRemy B Verheijen, Florence Atrafi, Jan H M Schellens, et al.Pageof 34